Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "YES Bank's rally has been stupendous, I am little afraid of shy of buying at current level. The view is that if the stock corrects, and believe me everything corrects then it becomes an excellent buying and that could take time." "Sun Pharmaceutical Industries is a buy, the stock is now on the verge of a breakout again from a narrow range. It is also benefiting from Dr Reddy's Laboratories debacle. It is probably a positional buy as well as a short-term trade," he said. "I am not very fond of Lupin; the charts are very hazy and haphazard and there is some good news, good for it but it has come down and has gone up. Then it comes down again. It is in a large trading range. I don’t see much prospects. Say stocks like Ajanta Pharma is probably much better or even Sun Pharmaceutical or Cipla also. So, Lupin is not a favourite."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
